Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-17

FDA Approved: LACOSAMIDE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's Original Application for a generic lacosamide product, enabling its marketing as an anticonvulsant for partial-onset seizures …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)